Skip to main content
Top

Drug Safety

Issue 8/2016

Content (9 Articles)

Current Opinion

Ethical and Practical Considerations in Removing Black Box Warnings from Drug Labels

James S. Yeh, Ameet Sarpatwari, Aaron S. Kesselheim

Original Research Article

Risk of Liver Injury Associated with Green Tea Extract in SLIMQUICK® Weight Loss Products: Results from the DILIN Prospective Study

Elizabeth X. Zheng, Simona Rossi, Robert J. Fontana, Raj Vuppalanchi, Jay H. Hoofnagle, Ikhlas Khan, Victor J. Navarro

Open Access Original Research Article

Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis

Megan E. B. Clowse, Steven R. Feldman, John D. Isaacs, Alexandra B. Kimball, Vibeke Strand, Richard B. Warren, Daniel Xibillé, Yan Chen, Donald Frazier, Jamie Geier, James Proulx, Amy Marren

Original Research Article

Artesunate/Amodiaquine-Induced Acute Extrapyramidal Reactions in Children and Younger Adults: Case Series Assessment

Mulugeta Russom, Dawit Tesfai, Semere Gebregiorgis, Abdulmumini Usman, Selam Mihreteab, Iyassu Bahta, Elsa Mekonnen, Selamawit Ghebrehiwet, Gelila Abrham

Open Access Original Research Article

The Impact of Experiencing Adverse Drug Reactions on the Patient’s Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands

Leàn Rolfes, Florence van Hunsel, Katja Taxis, Eugène van Puijenbroek

Letter to the Editor

Is Earlier Signal Detection Always Better?

Alan M. Hochberg, Stella Stergiopoulos